{"version":"1.0","type":"link","title":"IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial.","author_name":"Kohli N 외","author_url":"https://prs-insight.online/author/Kohli%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/54839","thumbnail_width":1200,"thumbnail_height":630}